Both Oracle Argus cloud and on-premise deployments have been tested and are fully compliant with the new EV system.
Oracle Argus, a platform that enables biopharmaceutical companies, medical device manufacturers, and contract research organisations to make faster and better safety decisions, optimise global compliance, and easily integrate with the Oracle Health Sciences Empirica platform for signal management, automates and streamlines the entire multi-vigilance lifecycle for drugs, vaccines, and devices from clinical trials through post-marketing surveillance.
The Oracle Cloud offers complete SaaS application suites for ERP, HCM and CX, plus best-in-class database Platform as a Service and Infrastructure as a Service from data centers throughout the Americas, Europe and Asia.
Halma acquires Rovers Medical Devices
boston Scientific granted FDA approval for AGENT Drug-Coated Balloon
Enable Injections names new chief operating officer
BridgeBio Pharma and Kyowa Kirin partner on infigratinib for skeletal dysplasias in Japan
Redwood Scientific signs agreement with Jeeva Clinical Trials
Tissue Regenix ships first allograft products in the EU post-HPRA approval
Kromek secures GBP1.3m grant for AI-powered radiation sensor project